Home > Offer to Buy > Liothyronine sodium T3 Na Aanabolic Powder For Bobybuilding nicol@pharmade.com
Liothyronine sodium T3 Na Aanabolic Powder For Bobybuilding nicol@pharmade.com
Inquiry
| Post Date: | Nov 10,2015 |
| Expiry Date: | Nov 09,2016 |
| Detailed Description: | Cas No. : Liothyronine sodium T3 Na Aanabolic Powder For Bobybuilding nicol@pharmade.com Liothyronine sodium T3 Na Aanabolic Powder For Bobybuilding nicol@pharmade.com Liothyronine sodium T3 Na Aanabolic Powder For Bobybuilding We supply Steroid Raw Powder,Injectable Steroids Oil and Peptides : http://www.powdersteroid.com / http://www.steroidspowders.wordpress.com Liothyronine sodium (nicol@pharmade.com / Skype:lifangfang68):Liothyronine sodium,T3,Liothyronine sodium Powder,T3 powder,Cytomel, Tertroxin, steroid raw powder, anabolic powder for bodybuildin,t3 Na Product name:T3 Na 1. CAS No.: 55-06-1 2. Molecular formula: C15H11I3NNaO4 3. Nolecular weight: 672.96 4. EINECS: 200-223-5 5. Appearence: white to beige powder 6. Usage: Liothyronine is a synthetic form of thyroid hormone (T3) used to treat hypothyroidism and myxedema coma. It is also used as an augmentation strategy in treating Major Depressive Disorder when used in combination with antidepressants 5. Delivery time: within 12 hours after payment down 6. Express: HKEMS,TNT,DHL,FedEx,UPS 7. Discounts: large quantity of each item and multiple items ordered 8. Payment terms: Western union,Money Gram,T/T bank transfer and Bitcoin. |
| Company: | Shenzhen Shijingu Technology Co., Ltd |
| Contact: | lifangfang |
| Tel: | 86-755-61938003 |
| Fax: | |
| Email: | Send Message |
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
